ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH ETANERCEPT-METHOTREXATE THERAPY IN SUBJECTS WITH MODERATELY ACTIVE RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS FROM THE PRESERVE TRIAL

被引：0
|
作者：
Smolen, Josef S. [1 ,2 ]
Freundlich, Bruce [3 ]
Pavelka, Karel [4 ,5 ]
Nash, Peter [6 ]
Miranda, Pedro [7 ,8 ]
Hammond, Constance [9 ]
Vlahos, Bonnie [9 ]
Pedersen, Ronald [9 ]
Koenig, Andrew S. [9 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Vienna, Austria
[2] Hietzing Hosp, Vienna, Austria
[3] Univ Penn, Dept Rheumatol, Philadelphia, PA 19104 USA
[4] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic
[5] Charles Univ Prague, Clin Rheumatol, Prague, Czech Republic
[6] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia
[7] Univ Chile, Dept Rheumatol, Santiago, Chile
[8] Hosp San Juan Dios, Santiago, Chile
[9] Pfizer Inc, Dept Specialty Care, Collegeville, PA USA
来源：
RHEUMATOLOGY | 2011年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：ii12 / ii12
页数：1
相关论文
共 50 条
  • [31] One-Year Results From the Canadian Methotrexate and Etanercept Outcome Study: A Randomized Trial of Etanercept and Methotrexate Versus Etanercept Alone in Rheumatoid Arthritis
    Pope, Janet E.
    Haraoui, Boulos
    Thorne, J. Carter
    Poulin-Costello, Melanie
    Vieira, Andrew
    Keystone, Edward
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S566 - S566
  • [32] In rheumatoid arthritis patients with stable low disease activity on etanercept plus methotrexate, continuation of etanercept is clinically and radiographically superior to discontinuation: results from a randomized, double-blind clinical trial
    Ostergaard, M.
    Franck-Larsson, K.
    Leirisalo-Repo, M.
    Uhlig, T.
    Jansson, M.
    Larsson, E.
    Brock, F.
    van Vollenhoven, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 30 - 31
  • [33] Preliminary Results of a Multicentre Randomised Controlled Trial of Etanercept and Methotrexate to Induce Remission in Patients with Newly Diagnosed Inflammatory Arthritis
    Villeneuve, Edith
    Nam, Jackie L.
    Hensor, Elizabeth
    Wakefield, Richard J.
    Conaghan, Philip G.
    Green, Mike J.
    Gough, Andrew K.
    Quinn, Mark
    Reece, Richard J.
    Cox, Sally R.
    Emery, Paul
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S960 - S961
  • [34] Remission rates in subjects with active early rheumatoid arthritis - 1 year results of the comet trial
    Emery, Paul
    Breedveld, Ferdinand
    Hall, Stephen
    Durez, Patrick
    Pedersen, Ronald
    Robertson, Deborah
    Koenig, Andrew S.
    Freundlich, Bruce
    RHEUMATOLOGY, 2008, 47 : II10 - II11
  • [35] ADHERENCE AND PERSISTENCE WITH TRIPLE NON-BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUG THERAPY AND ETANERCEPT-METHOTREXATE COMBINATION THERAPY IN US PATIENTS WITH RHEUMATOID ARTHRITIS
    Bonafede, M.
    Johnson, B. H.
    Tang, D.
    Shah, N.
    Harrison, D.
    Collier, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 335 - 335
  • [36] Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study
    Uhlig, Till
    Lie, Elisabeth
    Norvang, Vibeke
    Lexberg, Ase Stavland
    Rodevand, Erik
    Kroll, Frode
    Kalstad, Synove
    Olsen, Inge C.
    Kvien, Tore K.
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (04) : 716 - 723
  • [37] UTILITY OF VECTRA-DA™ ON ASSESSMENT OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND GOLIMUMAB RESPONSE: RESULTS OF A PILOT STUDY FROM A PHASE 3 TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY
    Lamberth, S.
    Cherkas, Y.
    Brodmerkel, C.
    Curran, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 581 - 582
  • [38] CAN THE ASSOCIATION OF CICLOSPORINE A AND METHOTREXATE MAINTAIN REMISSION/LOW DISEASE ACTIVITY INDUCED BY ETANERCEPT IN EARLY RHEUMATOID ARTHRITIS PATIENTS? EVALUATION BY MAGNETIC RESONANCE IMAGING
    Diamanti, A. Picchianti
    Argento, G.
    Podesta, E.
    Germano, V.
    Fazi, S.
    Migliore, A.
    David, V.
    D'Amelio, R.
    Lagana, B.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (01) : 301 - 305
  • [39] EFFECTIVENESS OF A RANDOMIZED STEP-DOWN TO METHOTREXATE OR LEFLUNOMIDE MAINTENANCE THERAPY IN PATIENTS WITH LOW DISEASE ACTIVITY, 40 WEEKS AFTER STARTING COMBINED METHOTREXATE-LEFLUNOMIDE REMISSION INDUCTION THERAPY IN EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE CARERA TRIAL
    Stouten, V.
    Michiels, S.
    Belba, A.
    Westhovens, R.
    Verschueren, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 967 - 968
  • [40] WHAT IS THE IMPACT OF POOR PROGNOSTIC FACTORS ON THE ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS?
    Baganz, L.
    Richter, A.
    Albrecht, K.
    Schneider, M.
    Burmester, G-R.
    Zink, A.
    Strangfeld, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 155 - 156
12345